Orphan drug developers to discuss how to bring therapies to market fasterThough orphan drug designations have increased across established markets like US, Europe and Japan, high rates of clinical attrition as well as pricing & reimbursement issues remain problematic. Join over 600 industry and key stakeholders next April where these issues will be discussed and debated!Join the 4th annual World Orphan Drug Congress USA, the largest global orphan drug conference! This will be held in Washington DC from April 23rd -25th, 2014.
No comments:
Post a Comment